About PrTMS®

---

TMS (Transcranial Magnetic Stimulation) and PrTMS (Personalized Repetitive Transcranial Magnetic Stimulation) are both non-invasive brain stimulation treatments used for depression, anxiety, PTSD, and other neurological conditions.

TMS delivers magnetic pulses to stimulate specific brain regions (usually the left dorsolateral prefrontal cortex) using standardized protocols. Treatment settings—such as coil position, frequency (e.g., 10 Hz), and intensity—are generally the same for all patients with a given condition.

PrTMS is an advanced, customized version of TMS. It begins with a qEEG (quantitative EEG) brainwave mapping to detect abnormal patterns in brain activity. Based on this data, stimulation parameters—coil placement, frequency, and intensity—are personalized for each patient. Protocols are reviewed and adjusted weekly, ensuring the treatment adapts to changes in the patient’s brain over time.

TMS should be avoided by individuals with implanted metallic or electronic devices in or near the head (e.g., cochlear implants, aneurysm clips, pacemakers), those with uncontrolled seizures, or certain brain injuries. Pregnant women and people with severe anxiety around magnetic stimulation should consult their doctor before treatment.

PrTMS therapy (Personalized Repetitive Transcranial Magnetic Stimulation) is a non-invasive, drug-free brain stimulation method designed to optimize brainwave activity. It begins with a qEEG brain map to detect irregular neural patterns, followed by a customized magnetic stimulation plan targeting specific brain regions. Unlike standard TMS, PrTMS is continuously adjusted through weekly qEEG readings, ensuring the treatment evolves with the patient’s progress. It is used for depression, anxiety, PTSD, concussion recovery, sleep disorders, ADHD, and cognitive enhancement. By fine-tuning brainwave rhythms, PrTMS helps improve mood, focus, and mental performance—essentially “retraining” the brain to function more efficiently.

PrTMS therapy (Personalized Repetitive Transcranial Magnetic Stimulation) is a non-invasive, drug-free brain stimulation method designed to optimize brainwave activity. It begins with a qEEG brain map to detect irregular neural patterns, followed by a customized magnetic stimulation plan targeting specific brain regions. Unlike standard TMS, PrTMS is continuously adjusted through weekly qEEG readings, ensuring the treatment evolves with the patient’s progress. It is used for depression, anxiety, PTSD, concussion recovery, sleep disorders, ADHD, and cognitive enhancement. By fine-tuning brainwave rhythms, PrTMS helps improve mood, focus, and mental performance—essentially “retraining” the brain to function more efficiently.

Yes, TMS therapy is often covered by insurance in the U.S. for FDA-approved conditions like major depressive disorder, provided other treatments have failed. Coverage depends on the insurer, medical necessity, and documentation. Patients should check specific policy requirements before starting treatment to avoid unexpected out-of-pocket expenses.

TMS uses magnetic pulses to stimulate targeted brain regions, especially those involved in mood regulation. This activation helps reset neural pathways, improve communication between brain cells, and enhance neurotransmitter activity, ultimately reducing symptoms of depression, anxiety, and other neurological or psychiatric conditions over time.

Signs that TMS is working include improved mood, reduced anxiety, better focus, enhanced sleep quality, and increased daily motivation. Some people notice subtle changes within 2–4 weeks, such as enjoying activities again or feeling less emotionally overwhelmed, which gradually build into more consistent mental and emotional well-being.

TMS does not change your core personality. Instead, it can help reduce symptoms of depression or anxiety, allowing your natural traits to emerge more fully. Many patients feel more like themselves—happier, calmer, and more engaged—without altering their fundamental character, values, or identity.

TMS has a success rate of about 60–70% for treatment-resistant depression, with around 30–50% achieving full remission. Effectiveness varies by condition and patient profile, but many experience significant symptom improvement, especially when combined with therapy or lifestyle changes, making it a promising option for those unresponsive to medication.

TMS has an average success rate of 50–60% for major depression, meaning about 40–50% of patients may not experience significant improvement. Failure rates can vary depending on condition severity, treatment adherence, and individual brain response, highlighting the need for alternative or combined therapies if TMS alone is ineffective.

TMS can be more effective than antidepressants for patients with treatment-resistant depression, offering improvement without systemic side effects. While antidepressants work for many, TMS benefits those who don't respond to medication, with longer-lasting relief in some cases. Effectiveness varies by individual, and combining both approaches may enhance results.

Yes. You are awake and sitting in a comfortable, reclining chair.

Yes. Absolutely, there is no downtime, and you can resume regular activities immediately. 

Typically, there are minimal to no side effects. Some people report a slight headache at the treatment area which quickly subsides. 

Yes. In certain cases such as MDD, anxiety and OCD. Some providers require one to two antidepressants to have been tried. 

Yes. It is safe for all ages and FDA-approved for adolescents and adults.